SurgeCare SAS

https://www.surge.care

LinkedIn: https://www.linkedin.com/company/surgecare

Founded with the goal of revolutionizing precision medicine, Surge is an innovative company specializing in in-depth understanding of the immune system using AI. Thanks to significant technological advancements and a team of top-notch researchers, Surge is committed to creating innovative solutions to pave the way for personalized medicine of tomorrow. With the launch of its first product, PreCyte®, for predicting the risk of postoperative complications, and its premier laboratory, SurgeLab™, for acquiring individualized immune signatures, the company aims to become a leader in precision immune analysis. *

	Start	2022-10-26 renamed
	Predecessor	Surge2Surgery SAS
	Industry	MedTech (medical technology)
	Person	Hédou, Julien (SurgeCare 202403 CEO + Co-Founder)

	Region	Illkirch
	Country	France
	Street	1 rue des Soeurs
	City	67400 Illkirch Graffenstaden
		Address record changed: 2024-03-30

Basic data	Employees	n. a.

		* Document for »About Section«: SurgeCare SAS. (3/27/24). "Press Release: Surge Announces Closing of a €7.5 Million Fundraising Round to Decrypt the Immune System and Transform Precision Medicine". Paris.

		Record changed: 2024-03-30

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for SurgeCare SAS

[1] SurgeCare SAS. (3/27/24). "Press Release: Surge Announces Closing of a €7.5 Million Fundraising Round to Decrypt the Immune System and Transform Precision Medicine". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]